Canine Olfaction Combined With Bayesian Modeling for Multicancer Detection From Breath Samples: A Phase II Study in India
Journal of Clinical Oncology · 01.07.2026 · 44 (19) · 1774-1783
DOI: 10.1200/jco-25-02310 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.07.2026. Verfasst von Sanjeev Kulgod und 15 weiteren Autor:innen. Beteiligte Einrichtung: RadOn Cancer Centre, Hubballi, India. Hauptthemen laut MEDLINE: Smell, Neoplasms, Working Dogs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Low-cost, acceptable, high-sensitivity triage tests are needed to address low cancer prevalence in population screening, particularly in low- and middle-income countries. Breath-based canine olfaction may serve this role, but evidence, to date, has been limited to small, single-cancer studies, largely from high-income settings. We evaluated the analytical validity of a multicancer breath detection system using trained dogs integrated with Bayesian fusion modeling. METHODS We conducted an assessor-masked, multicenter case-control study across six hospitals in Karnataka, India (CTRI/2024/10/075938). A total of 3,275 participants were enrolled (1,773 training; 1,502 testing). The test cohort included 283 treatment-naïve, biopsy-confirmed cancer cases spanning seven major cancer groups and 1,219 controls (healthy volunteers, nononcologic chronic disease, or benign biopsy). Breath was collected using cotton surgical masks, stored under –20°C cold-chain conditions, and evaluated by trained detection dogs. Individual dog indications were integrated using a Bayesian fusion framework incorporating historical dog performance and participant-level covariates. RESULTS The fusion system achieved 90.8% sensitivity (95% CI, 87.2 to 94.5) and 91.3% specificity (95% CI, 89.7 to 92.9), with a receiver operating characteristic AUC of 0.962 (95% CI, 0.952 to 0.969). The sensitivity for early-stage disease (stage I to II) was 90.6% and remained consistent across major cancer types. CONCLUSION In a 1,502-participant test cohort, canine olfaction combined with Bayesian fusion demonstrated high analytical accuracy for multicancer detection from breath. These findings establish analytical validity and support prospective evaluation in true screening populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- RadOn Cancer Centre, Hubballi, India.
- Karnataka Cancer Therapy and Research Institute, Hubballi, India.
- Karnataka Medical College and Research Institute, Hubballi, India.
- St John's Medical College, Bengaluru, India.
- Aster CMI Hospital, Bengaluru, India.
- Narayana Health City, Bengaluru, India.
ORCID-Profile: Kiran Kulkarni, Somashekhar Sp, Claire Guest, Rob Harris, Sahana Shanbhag, Sree Subha Ramaswamy, Itamar Bitan, Akash Kulgod
Zitieren
APA
Kulgod, S., Patil, B. R., Kallappa, S., Ramesh, R. S., Kulkarni, K., Sp, S., Majumdar, S., Singh, A., Guest, C., Harris, R., Aviram, I., Shanbhag, S., Parashar, A., Ramaswamy, S. S., Bitan, I., & Kulgod, A. (2026). Canine Olfaction Combined With Bayesian Modeling for Multicancer Detection From Breath Samples: A Phase II Study in India. Journal of Clinical Oncology, 44(19), 1774-1783. https://doi.org/10.1200/jco-25-02310
Vancouver
Kulgod S, Patil BR, Kallappa S, Ramesh RS, Kulkarni K, Sp S, et al. Canine Olfaction Combined With Bayesian Modeling for Multicancer Detection From Breath Samples: A Phase II Study in India. Journal of Clinical Oncology. 2026;44(19):1774-1783. doi:10.1200/jco-25-02310
BibTeX
@article{Kulgod2026,
author = {Kulgod, Sanjeev and Patil, Basavaraj R and Kallappa, Shashidhar and Ramesh, Rakesh S and Kulkarni, Kiran and Sp, Somashekhar and Majumdar, Swaratika and Singh, Akshita and Guest, Claire and Harris, Rob and Aviram, Ido and Shanbhag, Sahana and Parashar, Achin and Ramaswamy, Sree Subha and Bitan, Itamar and Kulgod, Akash},
title = {Canine Olfaction Combined With Bayesian Modeling for Multicancer Detection From Breath Samples: A Phase II Study in India},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {19},
pages = {1774--1783},
doi = {10.1200/jco-25-02310}
}
EUVIMED